STATE OF FLORIDA
DEPARTMENT OF HEALTH
CHAPTER 64D-3, FLORIDA ADMINISTRATIVE CODE
CONTROL OF COMMUNICABLE DISEASES AND
CONDITIONS WHICH MAY SIGNIFICANTLY AFFECT MAN
AMENDING SECTIONS 64D-3.002, 64D-3.003, 64D-3.004,
64D-3.006, 64D-3.013, 64D-3.015, AND 64D-3.016
CREATING SECTION 64D-3.027
64D-3.002 Notifiable Diseases or Conditions To Be Reported, Human.
(1) The following notifiable diseases or conditions are declared as dangerous to the
publics health or of public health significance. The occurrence
suspected occurrence of these diseases listed in Rule 64D-3.002, or the
suspected occurrence with the exception of cancer, congenital anomalies,
and HIV infection carriers of certain diseases listed in Rule 64D-3.013 in
any person, including persons who at the time of death were so affected, shall be
reported by licensed the attending practitioners as defined
in s.381.0031, F.S., Rule 64D-3.076 to the local county public
health department director or administrator or to their designated representative in
the county of the patients residence. Such reports shall be made within 72
48 hours of recognition by telephone, or other electronic means, or
in writing, except for certain specified diseases as indicated below by a (T) which shall
be reported immediately by telephone. Telephone reports shall be followed by a
subsequent written report. Exceptions to the reporting time frames required as defined
by this rule are provided for by syphilis, as indicated in
64D-3.016(3), and AIDS, as indicated in 64D-3.016(1)(a) 098(1)(a)1.,2.,
and congenital anomalies, as indicated in 64D-3.025(4). Cancer cases treated or
diagnosed by licensed practitioners as defined in s.381.0031, F.S., in medical
facilities licensed under Chapter 395, F.S., and in each freestanding
radiation therapy center as defined in s.408.07, F.S., shall be reported to the
Florida Cancer Data System as required by s.385.202, F.S., and by 64D-3.006.
(a) Acquired Immune Deficiency Syndrome (AIDS)
(c) Animal bite to humans
only by a potentially rabid animal
(d) Anthrax (T)
(e) Botulism (T)
(h) Cancer (except non melanoma skin cancer)
(j) Chlamydia trachomatis
(l) Congenital anomalies
(p) Diphtheria (T)
(q) Ehrlichiosis, human
Enteric disease due to Escherichia coli 0157:H7
(s) Enteric disease due to Escherichia coli O157:H7 (T)
disease due to other pathogenic Escherichia coli (including enterotoxigenic,
enteroinvasive, enteropathogenic, enterohemorrhagic, and enteroaggregative strains)
(t) Enteric disease due to other pathogenic Escherichia coli (including
enterotoxigenic, enteroinvasive, enteropathogenic, enterohemorrhagic, and
(u) Giardiasis (acute)
(w) Granuloma Inguinale
Haemophilus Influenzae Type b invasive disease
(x) Haemophilus influenzae type b invasive disease
(y) Hansens Disease (Leprosy)
(z) Hantavirus Infection (T)
Hemolytic Uremic Syndrome
(aa) Hemolytic Uremic Syndrome
Hemorrhagic Fever (T)
(bb) Hemorrhagic Fever (T)
(cc) Hepatitis, viral A (T), B, C, non-A non-B, and other including unspecified
(dd) Hepatitis, viral, positive B surface antigen in a pregnant woman or in a child
<25 months of age
(ee) Human Immunodeficiency Virus (HIV)
(ff) Lead Poisoning
(ii) Listeriosis (T)
(jj) Lyme Disease
(kk) Lymphogranuloma Venereum
(mm) Measles (T)
(nn) Meningitis, bacterial and mycotic
(oo) Meningococcal Disease (T)
(pp) Mercury Poisoning (T)
Paralytic Shellfish Poisoning (T)
(rr) Neurotoxic Shellfish Poisoning (T)
(tt) Pesticide Poisoning
(uu) Plague (T)
(vv) Poliomyelitis (T)
Rocky Mountain Spotted Fever R. rickettsia
(yy) Rocky Mountain Spotted Fever, R. rickettsia
(zz) Rubella, including congenital
Streptococcal Disease, invasive, Grp A
(ccc) Smallpox (T)
Streptococcal Toxic Shock Syndrome
(ddd) Staphylococcus aureus, glycopeptide (vancomycin) intermediate
Streptococcus pneumoniae, drug resistant
(eee) Staphylococcus aureus, glycopeptide (vancomycin) resistant (GRSA/VRSA,
MIC= >32mg/ml) (T)
(fff) Streptococcal Disease, invasive, Group A
(ggg) Streptococcus pneumoniae, invasive disease
(jjj) Toxic Shock Syndrome, staphylococcal or streptococcal
(kkk) Toxoplasmosis, acute
Vibrio cholera (T)
(nnn) Tularemia (T)
(ooo) Typhoid Fever
Yellow Fever (T)
(ppp) Vibrio cholerae (T)
Any disease outbreak in a community, a
hospital, or other institution, or a foodborne, or waterborne outbreak as
defined in Rule 10D-3.064.
(qqq) Vibrio Infections
(rrr) Yellow Fever (T)
(sss) Any disease outbreak in a community, a hospital, or other institution, or a foodborne, or waterborne outbreak (T)
(2) The D
department periodically will periodically
list additional diseases and conditions on its reporting forms for which reporting is
encouraged but not required.
Specific Authority 381.0011(4), (13), 381.003(2), 381.0031(5), 384.33,
392.53, 392.66, FS. Law Implemented
154.01, 381.0011(4), 381.003(1),
381.0031 (1),(2),(5) (FL. Laws Chap 98-151), 384.23, 384.25,
385.202, 392.53, FS. History - New 12-29-77, Amended 6-7-82, 11-6-85, Formerly
10D-3.62, Amended 2-26-92, 9-7-93, 11-1-94, 7-21-96, Formerly 10D-3.062, Amended 11-2-98. Amended
64D-3.003 Notification by Laboratories.
(2) All reports of cancer identified by laboratories licensed under Chapter 483, F.S., shall be submitted to the Florida Cancer Data System within six (6) months of diagnosis.
(3) The State Health Officer shall periodically, but no less than annually, issue a listing of laboratory test results that are to be reported. The March 1999 "Reportable Laboratory Findings," incorporated by reference in this rule, shall be updated to reflect changes in technology and practice and may be obtained from the Department of Health, Bureau of Epidemiology, 2020 Capital Circle S.E., Bin A12, Tallahassee, Florida 32399-1734.
(4) To allow follow-up of laboratory findings by the local county health department director/administrator or their designee, all specimens submitted for laboratory tests or examinations related to a disease or condition listed in 64D-3.002(1) shall be accompanied by certain identifying information. In addition to the name and date of birth of the person from whom the specimen was obtained; the name, address and telephone number of the processing clinical laboratory; and the diagnostic test(s) performed, specimen type and result, the following information shall be provided:
(a) Address, telephone number, race, sex, and ethnicity of the person from whom the specimen was obtained or, if this is not available,
(5) The practitioner who first authorizes, orders, requests or submits a specimen shall be responsible for obtaining and providing the information required in (4) above at the time the specimen is sent to or received by the laboratory.
(6) Notification of test results shall be submitted by telephone, or other electronic means, or in writing on a form furnished by the laboratory. Reports shall be made within 72 hours of a test result. Any preliminary telephone communication must be followed up by a written report.
(7) If the laboratory that makes the positive finding received the specimen from another laboratory, the laboratory making the positive finding shall be responsible for reporting such results as defined in 64D-3.003(1).
(8) In addition to the reporting requirements pursuant to 64D-3.003(1), each laboratory that obtains a human isolate of Escherichia coliO157:H7, or Neisseria meningitidis or Haemophilus influenzae from a sterile site shall retain a subculture of the isolate on suitable media for at least six months after receipt of the specimen in the laboratory. In lieu of retaining this subculture, the laboratory is permitted to send the subculture to the Florida Department of Health State Central Laboratory, which will maintain a record indicating the date that these subcultures were submitted to the Central Laboratory.
(9) In addition to the reporting requirements pursuant to 64D-3.003(1), each laboratory that makes a finding, or suggestive finding, of malaria or cyclospora parasites in a specimen of a patient shall retain a stained permanent slide for at least six months after receipt of the specimen in the laboratory. In lieu of retaining the slide(s), the laboratory may send such slide(s) to the State of Florida Department of Health Central Laboratory, which will maintain a record indicating the date that these specimens were submitted to the Central Laboratory.
(10) Each laboratory licensed to perform tests for any reportable disease or condition shall make its records for such diseases or conditions available for on-site inspection by the department or its authorized representatives.
Specific Authority 381.0011(13), 381.003
(1)(d), (2), 381.0031(5) ,
384.33 FS. Law Implemented 154.01, 381.0011(4), 381.003(1),
381.0031 (1),(5), (Fl. Laws Chap.98-151), 384.25 FS.
HistoryNew 12-29-77, Amended 6-7-82, Formerly 10D-3.66, Amended 2-26-92, 7-21-96,
Formerly 10D-3.066, Amended 11-2-98. Amended __________.
64D-3.004 Notifiable Disease Case Report Content.
All notifiable disease case reports required by Sections 64D-3.002 and 64D-3.003 shall contain the diagnosis, name, address, age, sex, and race and ethnicity if known, and age of each case.
Specific Authority 381.0011(4), (13), 381.003
(1)(d), (2), 381.0031 (1),
(5), 384.25 FS. Law Implemented 381.0011(4), 381.003(1), 381.0031 (1)
FS. History New 12-29-77, Amended 6-7-82, Formerly 10D-3.68, 10D-3.068. Amended ___________.
64D-3.006 Reports, Medical Facilities and Freestanding Radiation Therapy Centers
(1) No change
(2) Reporting of a case or suspected case of notifiable disease or condition
by a facility or center fulfills the requirements of the licensed
practitioner to report; however, it is the responsibility of the attending
practitioner to ensure that the report is made as stipulated in Section
64D-3.002. Reports shall be made within 72 hours of diagnosis. Exceptions to
medical facility and center reporting as defined by this rule are provided for sexually
transmissible diseases, including HIV infection, as indicated in 64D-3.016, and for
cancer, as indicated in 64D-3.006(3).
(3) Reporting of cancer cases by a licensed practitioner, a hospital facility licensed under Chapter 395, F.S., and freestanding radiation therapy centers, as defined in s.408.07, F.S., to the Florida Cancer Data System as required by Section 385.202, F.S., shall be accomplished within six (6) months of the date of each diagnosis and within six (6) months of the date of each treatment.
381, 381.0011(13), 381.003 (1)(d),
(2), 381.0031(5), 384, 384.33 FS. Law Implemented 381.0011,
381.003, 381.0031 (5) (Fl. Laws Chap. 98-151), 384.25,
385.202, 392.53 FS. History New 12-29-77, Amended 6-7-82, Formerly 10D-3.77.
Amended 2-26-92, 7-21-96, Formerly 10D-3.077, Amended 11-2-98. Amended ______________.
64D-3.013 Procedures for Control of Specific Communicable Diseases
(b) Prevention in Humans Persons bitten or otherwise exposed to suspect rabid
animals shall be evaluated for post-exposure treatment by the county health department
director/medical director or the S
state H health
O officer according to recommendations of the Immunization
Practices Advisory Committee published in the Centers for Disease Control and Prevention
Morbidity and Mortality Weekly R report, No. RR-1, January 8,
1999, incorporated by reference in this rule. This document may be obtained from the
Department of Health, Bureau of Epidemiology, 2020 Capital Circle S.E., Bin A12,
Tallahassee, Florida 32399-1734.
1. The State Health Officer or his designated representative, with the current
approval of the Secretary of the Department, or the county health department director or
administrator or his designated representatives may declare an area wide quarantine when
prevalence of rabies so indicates. The conditions of the quarantine may control the
movement, sale, impoundment and required euthanization of animals in the quarantine
vaccination area as defined by departmental policy and procedure
guidelines , and CDC and NASPPHV recommended actions.
(a) through (b) No change
(6) No change.
120.535, 381.0011 (8), (13),
381.003(2), 381.006, 384.25(2), 384.33, FS. Law Implemented 381.0011(4), (8),
381.003(1), 381.0031, 384.27, FS. HistoryNew 12-29-77, Amended 6-14-78,
6-7-82, 11-6-85, Formerly 10D-3.91, Amended 7-5-87, 7-19-89, 2-26-92, 10-20-93, 11-1-94,
7-21-96, Formerly 10D-3.091. Amended _________.
64D-3.015 Diseases Designated as Sexually Transmissible Diseases.
(f) Hepatitis B
Human Immunodeficiency Virus Infection
(g) Human Immunodeficiency Virus Infection
(h) Lymphogranuloma Venereum
(2) No change
Specific Authority 381.0011
(4), (13), 381.003 (1)(b), (c),
(d), (2), 384.23, 384.25(2), 384.33 FS. Law
Implemented 381.0011(4), (8), (13), 381.003(1), 384.21,
384.23 FS. History New 7-5-87, Amended 9-7-93, 5-20-96, 1-1-97, Formerly 10D-3.096.
64D-3.016 Reporting Requirements for Physicians for sexually Transmissible Diseases (STDs), Including HIV and AIDS.
(1) No change
(b) Except for AIDS,
and HIV and hepatitis B reports,
all reports of sexually transmissible diseases shall be submitted on the Florida
Confidential Report of Sexually Transmitted Diseases, DOH Form 720, effective 7-5-87. The
form, incorporated by reference in this rule, will be furnished by the local county health
(c) through (d) No change
(2) through (4) No change.
Specific Authority 381.0011(13), 381.003(2), 381.0031(5), 384.25(2), 384.33 FS.
Law Implemented 381.0011, 381.003(1), 384.25
, 458, 459 FS. History
New 7-5-87, Amended 2-7-90, 2-26-92, 5-20-96, 1-1-97, Formerly 10D-3.097. Amended
64D-3.027 Reporting of Congenital Anomalies.
(3) The reporting of congenital anomalies shall apply to each infant or fetus born, expelled, or extracted in Florida on July 4, 1999, or later.
(4) A licensed hospital, or licensed practitioner as defined in s.381.0031(1), F.S., shall report information regarding each notifiable congenital anomaly according to the definitions, coding schemes, instructions, and reporting forms contained in the above referenced Data Reporting Manual.
(a) Each hospital licensed under Chapter 395, F.S., shall report to the Florida Birth Defects Registry each notifiable congenital anomaly occurring in an infant admitted to the hospital. If a hospital reports a congenital anomaly to the Agency for Health Care Administration in its inpatient discharge data report pursuant to Chapter 59E-7, F.A.C., then it need not comply with the reporting requirements of 64D-3.027 for that anomaly.
(c) Physician or hospital reports shall be made no sooner than the date of birth, expulsion, or extraction, and no later than 60 days after the date on which the diagnosis was made, or the date of birth, expulsion, or extraction, whichever is later, except as indicated in 64D-3.027(4)(a).
Specific Authority 381.0011(13), 381.0031(5),FS. Law Implemented 381.0011(7), 381.0031, FS. History New .